Christopher R Heery | Chief Medical Officer
Precision BioSciences

Christopher R Heery, Chief Medical Officer, Precision BioSciences

Chris Heery, MD, is the Chief Medical Officer at Precision BioSciences. Prior to joining Precision, Dr. Heery served as Chief Medical Officer of Bavarian Nordic where he oversaw clinical development programs for its immune-oncology and infectious diseases portfolios. Prior to this, he was Head of the Clinical Trials Group of the Laboratory of Tumor Immunology and Biology at NCI. He joined the NCI Medical Oncology Branch as a Medical Oncology Fellow in 2009 and also held an Adjunct Appointment in the Genitourinary Malignancies Branch. At NCI, Dr. Heery was part of the larger effort of the Laboratory of Tumor Immunology and Biology to create new immunotherapies for the treatment of cancer. He is board certified in Medical Oncology and Internal Medicine and completed his internal medicine residency at the University of Illinois at Chicago after receiving his M.D. from East Carolina University Brody School of Medicine. Dr. Heery also holds a B.A. in English Literature from Duke University.

Appearances:



Conference Day 1 - Tuesday 31st March 2020 @ 09:20

Realizing the promise of ATMPs for patients around the world

  • Working with regulators to navigate scale up challenges in manufacturing
  • Strategies in supply chain and patient delivery
  • Tackling post manufacturing commercialization challenges such as pricing and finding highly skilled experts
  • Durability

Conference Day 2 - Wednesday 1st April 2020 @ 12:00

Allogenic CAR T in the clinic and prospects for making CAR T more accessible to patients

last published: 05/Dec/19 09:46 GMT

back to speakers